Center for Scientific Review; Notice of Closed Meeting, 11189 [2010-5018]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 46 / Wednesday, March 10, 2010 / Notices
11189
Date: April 12, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call.)
Contact Person: Robert Wellner, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes Of Health,
Room 757, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452. (301) 594–4721.
rw175w@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 2, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information
Coordination.
Dated: March 2, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–5018 Filed 3–9–10; 8:45 am]
[Docket No. FDA–2010–N–0107]
Dated: March 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Health Resources and Services
Administration
BILLING CODE 4140–01–P
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
erowe on DSK5CLS3C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cellular and Developmental
Neuroscience.
Date: March 24, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Deborah L. Lewis, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–408–
9129, lewisdeb@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
VerDate Nov<24>2008
15:07 Mar 09, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
Food and Drug Administration
BILLING CODE 4140–01–P
Bureau of Health Professions; All
Advisory Committee Meeting; Notice of
Meeting
[FR Doc. 2010–5019 Filed 3–9–10; 8:45 am]
[FR Doc. 2010–5006 Filed 3–9–10; 8:45 am]
Name: Bureau of Health Professions AllAdvisory Committee Meeting (AACM).
Dates and Times: April 21, 2010, 8 a.m.–
5 p.m.
Place: Doubletree Hotel & Executive
Meeting Center, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Telephone: 301–652–2000.
Status: The meeting will be open to the
public.
Purpose: The purpose of the meeting is to
provide a venue for the Bureau of Health
Professions’ (BHPr) four advisory committees
[the Council on Graduate Medical Education
(COGME), the Advisory Committee on
Training in Primary Care Medicine and
Dentistry (ACTPCMD), the Advisory
Committee on Interdisciplinary, CommunityBased Linkages (ACICBL), and the National
Advisory Council on Nurse Education and
Practice (NACNEP)] to continue their joint
work on interdisciplinary education and
practice, and to also discuss and identify
future opportunities for collaboration.
Agenda: The AACM agenda will include
updates on Bureau and Departmental
priorities, discussion of the joint work on
interdisciplinary education and practice, and
proposals for future Advisory Committee
collaboration. Agenda items are subject to
change as priorities dictate.
For Further Information Contact:
Anyone interested in obtaining a roster of
members, minutes of the meeting, or other
relevant information can contact the Bureau
of Health Professions, Office of the Associate
Administrator, 5600 Fishers Lane, room 9–
05, Rockville, Maryland, 20857, telephone
(301) 443–5794. Information can also be
found at the following Web site: https://
bhpr.hrsa.gov/.
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
Expanded Access to Direct-Acting
Antiviral Agents for the Treatment of
Chronic Hepatitis C Infection in
Patients With Unmet Medical Need;
Public Hearing; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
ACTION: Notice of public hearing; request
for comments.
SUMMARY: The Food and Drug
Administration (FDA or the agency) is
announcing a public hearing to obtain
input on the scope and implementation
of potential expanded access programs
with direct-acting antiviral agents
(DAAs) for the treatment of chronic
hepatitis C (CHC) infection in patients
with unmet medical need. This public
hearing is being held to obtain
comments from the public on eligibility
criteria that should be used for patient
enrollment in expanded access
protocols involving DAAs and to elicit
suggestions for designs of protocols for
treatment investigational new drug
applications (INDs) involving DAAs and
other expanded access protocols. In
addition, the agency would like public
input on types of studies that should be
conducted to obtain information on
patients with unmet medical need
including those with the greatest risk of
progression of liver disease and/or the
lowest predicted virologic response
rates.
DATES: The public hearing will be held
April 30, 2010, from 9 a.m. to 4 p.m.
The meeting may be extended or may
end early depending on the level of
public participation. Submit written or
electronic requests for oral presentations
and comments by April 8, 2010 (see
section III of this document for details).
Written or electronic comments will be
accepted after the hearing until June 25,
2010 (see section V of this document for
details).
ADDRESSES: The public hearing will be
held at the Hilton Hotel, 1750 Rockville
Pike, Rockville, MD 20852. Additional
information on parking and public
transportation may be accessed at https://
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 75, Number 46 (Wednesday, March 10, 2010)]
[Notices]
[Page 11189]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cellular and Developmental Neuroscience.
Date: March 24, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Deborah L. Lewis, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892, 301-408-9129, lewisdeb@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 2, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-5018 Filed 3-9-10; 8:45 am]
BILLING CODE 4140-01-P
